LOCUS       NM_000417               3216 bp    mRNA    linear   PRI 02-SEP-2018
DEFINITION  Homo sapiens interleukin 2 receptor subunit alpha (IL2RA),
            transcript variant 1, mRNA.
ACCESSION   NM_000417
VERSION     NM_000417.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 3216)
  AUTHORS   Sadras T, Heatley SL, Kok CH, Dang P, Galbraith KM, McClure BJ,
            Muskovic W, Venn NC, Moore S, Osborn M, Revesz T, Moore AS, Hughes
            TP, Yeung D, Sutton R and White DL.
  TITLE     Differential expression of MUC4, GPR110 and IL2RA defines two
            groups of CRLF2-rearranged acute lymphoblastic leukemia patients
            with distinct secondary lesions
  JOURNAL   Cancer Lett. 408, 92-101 (2017)
   PUBMED   28866095
  REMARK    GeneRIF: High IL2RA expression is associated with CRLF2-rearranged
            acute lymphoblastic leukemia.
REFERENCE   2  (bases 1 to 3216)
  AUTHORS   Schwedhelm K, Thorpe J, Murray SA, Gavin M, Speake C, Greenbaum C,
            Cerosaletti K, Buckner J and Long SA.
  TITLE     Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is
            intrinsic and dependent on activation state
  JOURNAL   Clin. Immunol. 181, 67-74 (2017)
   PUBMED   28645874
  REMARK    GeneRIF: In T1D, low IL-2 responsiveness was most pronounced in
            memory T effector cells. Reduced IL-2 responses in memory T
            effector cells were not rescued by resting, remained lower after
            activation and proliferation, and were absent in type 2 diabetes.
REFERENCE   3  (bases 1 to 3216)
  AUTHORS   Nukui A, Masuda A, Abe H, Arai K, Yoshida KI and Kamai T.
  TITLE     Increased serum level of soluble interleukin-2 receptor is
            associated with a worse response of metastatic clear cell renal
            cell carcinoma to interferon alpha and sequential VEGF-targeting
            therapy
  JOURNAL   BMC Cancer 17 (1), 372 (2017)
   PUBMED   28545581
  REMARK    GeneRIF: Increased serum level of soluble interleukin-2 receptor is
            associated with a worse response of metastatic clear cell renal
            cell carcinoma to interferon alpha and sequential VEGF-targeting
            therapy.
            Publication Status: Online-Only
REFERENCE   4  (bases 1 to 3216)
  AUTHORS   Buhelt S, Ratzer RL, Christensen JR, Bornsen L, Sellebjerg F and
            Sondergaard HB.
  TITLE     Relationship between soluble CD25 and gene expression in healthy
            individuals and patients with multiple sclerosis
  JOURNAL   Cytokine 93, 15-25 (2017)
   PUBMED   28511943
  REMARK    GeneRIF: Relationship between soluble CD25 and gene expression in
            healthy individuals and patients with multiple sclerosis.
REFERENCE   5  (bases 1 to 3216)
  AUTHORS   Bharwani KD, Dirckx M, Stronks DL, Dik WA, Schreurs MWJ and Huygen
            FJPM.
  TITLE     Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome:
            A Pathogenic Role for T-Lymphocytes?
  JOURNAL   Mediators Inflamm. 2017, 2764261 (2017)
   PUBMED   28634419
  REMARK    GeneRIF: sIL-2R could be a promising new marker for determining
            inflammatory disease activity in CRPS.
REFERENCE   6  (bases 1 to 3216)
  AUTHORS   Purvis SF, Georges DL, Williams TM and Lederman MM.
  TITLE     Suppression of interleukin-2 and interleukin-2 receptor expression
            in Jurkat cells stably expressing the human immunodeficiency virus
            Tat protein
  JOURNAL   Cell. Immunol. 144 (1), 32-42 (1992)
   PUBMED   1394441
REFERENCE   7  (bases 1 to 3216)
  AUTHORS   Carter CR, Hancock BW and Rees RC.
  TITLE     The augmentation of lymphokine-activated killer activity following
            pulsing of human peripheral blood mononuclear cells with
            recombinant human interleukin-2
  JOURNAL   Cancer Immunol. Immunother. 35 (4), 264-270 (1992)
   PUBMED   1511461
REFERENCE   8  (bases 1 to 3216)
  AUTHORS   Kanegane H, Miyawaki T, Kato K, Yokoi T, Uehara T, Yachie A and
            Taniguchi N.
  TITLE     A novel subpopulation of CD45RA+ CD4+ T cells expressing IL-2
            receptor alpha-chain (CD25) and having a functionally transitional
            nature into memory cells
  JOURNAL   Int. Immunol. 3 (12), 1349-1356 (1991)
   PUBMED   1685671
REFERENCE   9  (bases 1 to 3216)
  AUTHORS   Kuziel WA and Greene WC.
  TITLE     Interleukin-2 and the IL-2 receptor: new insights into structure
            and function
  JOURNAL   J. Invest. Dermatol. 94 (6 Suppl), 27S-32S (1990)
   PUBMED   1693645
  REMARK    Review article
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AL157395.17, X01057.1 and
            AL137186.18.
            On Nov 28, 2009 this sequence version replaced NM_000417.1.
            
            Summary: The interleukin 2 (IL2) receptor alpha (IL2RA) and beta
            (IL2RB) chains, together with the common gamma chain (IL2RG),
            constitute the high-affinity IL2 receptor. Homodimeric alpha chains
            (IL2RA) result in low-affinity receptor, while homodimeric beta
            (IL2RB) chains produce a medium-affinity receptor. Normally an
            integral-membrane protein, soluble IL2RA has been isolated and
            determined to result from extracellular proteolyisis.
            Alternately-spliced IL2RA mRNAs have been isolated, but the
            significance of each is presently unknown. Mutations in this gene
            are associated with interleukin 2 receptor alpha
            deficiency.[provided by RefSeq, Nov 2009].
            
            Transcript Variant: This variant (1) represents the longest
            transcript and encodes the longest isoform (1).
            
            Sequence Note: This RefSeq record was created from transcript and
            genomic sequence data to make the sequence consistent with the
            reference genome assembly. The genomic coordinates used for the
            transcript record were based on transcript alignments.
            
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            
            ##Evidence-Data-START##
            Transcript exon combination :: X01057.1, AK223313.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
                                           SAMEA2142670, SAMEA2151358
                                           [ECO:0000348]
            ##Evidence-Data-END##
            COMPLETENESS: complete on the 3' end.
PRIMARY     REFSEQ_SPAN         PRIMARY_IDENTIFIER PRIMARY_SPAN        COMP
            1-62                AL157395.17        6404-6465           c
            63-2367             X01057.1           24-2328
            2368-3216           AL137186.18        144397-145245       c
FEATURES             Location/Qualifiers
     source          1..3216
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="10"
                     /map="10p15.1"
     gene            1..3216
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /note="interleukin 2 receptor subunit alpha"
                     /db_xref="GeneID:3559"
                     /db_xref="HGNC:HGNC:6008"
                     /db_xref="MIM:147730"
     exon            1..283
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     STS             141..1238
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /db_xref="UniSTS:489660"
     misc_feature    148..150
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /note="upstream in-frame stop codon"
     CDS             220..1038
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /note="isoform 1 precursor is encoded by transcript
                     variant 1; TAC antigen; IL-2R subunit alpha; IL-2 receptor
                     subunit alpha; interleukin 2 receptor, alpha"
                     /codon_start=1
                     /product="interleukin-2 receptor subunit alpha isoform 1
                     precursor"
                     /protein_id="NP_000408.1"
                     /db_xref="CCDS:CCDS7076.1"
                     /db_xref="GeneID:3559"
                     /db_xref="HGNC:HGNC:6008"
                     /db_xref="MIM:147730"
                     /translation="MDSYLLMWGLLTFIMVPGCQAELCDDDPPEIPHATFKAMAYKEG
                     TMLNCECKRGFRRIKSGSLYMLCTGNSSHSSWDNQCQCTSSATRNTTKQVTPQPEEQK
                     ERKTTEMQSPMQPVDQASLPGHCREPPPWENEATERIYHFVVGQMVYYQCVQGYRALH
                     RGPAESVCKMTHGKTRWTQPQLICTGEMETSQFPGEEKPQASPEGRPESETSCLVTTT
                     DFQIQTEMAATMETSIFTTEYQVAVAGCVFLLISVLLLSGLTWQRRQRKSRRTI"
     sig_peptide     220..282
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="COORDINATES: ab initio prediction:SignalP:4.0"
     mat_peptide     283..1035
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /product="Interleukin-2 receptor subunit alpha"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P01589.1)"
     misc_feature    940..996
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /note="propagated from UniProtKB/Swiss-Prot (P01589.1);
                     transmembrane region"
     exon            284..475
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            476..586
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            587..802
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            803..874
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            875..946
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            947..1013
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     exon            1014..3216
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /inference="alignment:Splign:2.1.0"
     STS             1029..1893
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /standard_name="IL2RA_V107"
                     /db_xref="UniSTS:277378"
     STS             1058..1262
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /standard_name="STS-X01057"
                     /db_xref="UniSTS:82054"
     regulatory      1337..1342
                     /regulatory_class="polyA_signal_sequence"
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
     polyA_site      1349
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
     STS             2132..2160
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /standard_name="D3S1674"
                     /db_xref="UniSTS:148451"
     STS             2141..2257
                     /gene="IL2RA"
                     /gene_synonym="CD25; IDDM10; IL2R; IMD41; p55; TCGFR"
                     /standard_name="D22S296"
                     /db_xref="UniSTS:147641"
ORIGIN      
        1 ggcagtttcc tggctgaaca cgccagccca atacttaaag agagcaactc ctgactccga
       61 tagagactgg atggacccac aagggtgaca gcccaggcgg accgatcttc ccatcccaca
      121 tcctccggcg cgatgccaaa aagaggctga cggcaactgg gccttctgca gagaaagacc
      181 tccgcttcac tgccccggct ggtcccaagg gtcaggaaga tggattcata cctgctgatg
      241 tggggactgc tcacgttcat catggtgcct ggctgccagg cagagctctg tgacgatgac
      301 ccgccagaga tcccacacgc cacattcaaa gccatggcct acaaggaagg aaccatgttg
      361 aactgtgaat gcaagagagg tttccgcaga ataaaaagcg ggtcactcta tatgctctgt
      421 acaggaaact ctagccactc gtcctgggac aaccaatgtc aatgcacaag ctctgccact
      481 cggaacacaa cgaaacaagt gacacctcaa cctgaagaac agaaagaaag gaaaaccaca
      541 gaaatgcaaa gtccaatgca gccagtggac caagcgagcc ttccaggtca ctgcagggaa
      601 cctccaccat gggaaaatga agccacagag agaatttatc atttcgtggt ggggcagatg
      661 gtttattatc agtgcgtcca gggatacagg gctctacaca gaggtcctgc tgagagcgtc
      721 tgcaaaatga cccacgggaa gacaaggtgg acccagcccc agctcatatg cacaggtgaa
      781 atggagacca gtcagtttcc aggtgaagag aagcctcagg caagccccga aggccgtcct
      841 gagagtgaga cttcctgcct cgtcacaaca acagattttc aaatacagac agaaatggct
      901 gcaaccatgg agacgtccat atttacaaca gagtaccagg tagcagtggc cggctgtgtt
      961 ttcctgctga tcagcgtcct cctcctgagt gggctcacct ggcagcggag acagaggaag
     1021 agtagaagaa caatctagaa aaccaaaaga acaagaattt cttggtaaga agccgggaac
     1081 agacaacaga agtcatgaag cccaagtgaa atcaaaggtg ctaaatggtc gcccaggaga
     1141 catccgttgt gcttgcctgc gttttggaag ctctgaagtc acatcacagg acacggggca
     1201 gtggcaacct tgtctctatg ccagctcagt cccatcagag agcgagcgct acccacttct
     1261 aaatagcaat ttcgccgttg aagaggaagg gcaaaaccac tagaactctc catcttattt
     1321 tcatgtatat gtgttcatta aagcatgaat ggtatggaac tctctccacc ctatatgtag
     1381 tataaagaaa agtaggttta cattcatctc attccaactt cccagttcag gagtcccaag
     1441 gaaagcccca gcactaacgt aaatacacaa cacacacact ctaccctata caactggaca
     1501 ttgtctgcgt ggttcctttc tcagccgctt ctgactgctg attctcccgt tcacgttgcc
     1561 taataaacat ccttcaagaa ctctgggctg ctacccagaa atcattttac ccttggctca
     1621 atcctctaag ctaaccccct tctactgagc cttcagtctt gaatttctaa aaaacagagg
     1681 ccatggcaga ataatctttg ggtaacttca aaacggggca gccaaaccca tgaggcaatg
     1741 tcaggaacag aaggatgaat gaggtcccag gcagagaatc atacttagca aagttttacc
     1801 tgtgcgttac taattggcct ctttaagagt tagtttcttt gggattgcta tgaatgatac
     1861 cctgaatttg gcctgcacta atttgatgtt tacaggtgga cacacaaggt gcaaatcaat
     1921 gcgtacgttt cctgagaagt gtctaaaaac accaaaaagg gatccgtaca ttcaatgttt
     1981 atgcaaggaa ggaaagaaag aaggaagtga agagggagaa gggatggagg tcacactggt
     2041 agaacgtaac cacggaaaag agcgcatcag gcctggcacg gtggctcagg cctataaccc
     2101 cagctcccta ggagaccaag gcgggagcat ctcttgaggc caggagtttg agaccagcct
     2161 gggcagcata gcaagacaca tccctacaaa aaattagaaa ttggctggat gtggtggcat
     2221 acgcctgtag tcctagccac tcaggaggct gaggcaggag gattgcttga gcccaggagt
     2281 tcgaggctgc agtcagtcat gatggcacca ctgcactcca gcctgggcaa cagagcaaga
     2341 tcctgtcttt aaggaaaaaa agacaagatg agcataccag cagtccttga acattatcaa
     2401 aaagttcagc atattagaat caccgggagg ccttgttaaa agagttcgct gggcccatct
     2461 tcagagtctc tgagttgttg gtctggaata gagccaaatg ttttgtgtgt ctaacaattc
     2521 ccaggtgctg ttgctgctgc tactattcca ggaacacact ttgagaacca ttgtgttatt
     2581 gctctgcacg cccacccact ctcaactccc acgaaaaaaa tcaacttcca gagctaagat
     2641 ttcggtggaa gtcctggttc catatctggt gcaagatctc ccctcacgaa tcagttgagt
     2701 caacattcta gctcaacaac atcacacgat taacattaac gaaaattatt catttgggaa
     2761 actatcagcc agttttcact tctgaagggg caggagagtg ttatgagaaa tcacggcagt
     2821 tttcagcagg gtccagattc agattaaata actattttct gtcatttctg tgaccaacca
     2881 catacaaaca gactcatctg tgcactctcc ccctccccct tcaggtatat gttttctgag
     2941 taaagttgaa aagaatctca gaccagaaaa tatagatata tatttaaatc ttacttgagt
     3001 agaactgatt acgacttttg ggtgttgagg ggtctataag atcaaaactt ttccatgata
     3061 atactaagat gttatcgacc atttatctgt ccttctctca aaagtgtatg gtggaatttt
     3121 ccagaagcta tgtgatacgt gatgatgtca tcactctgct gttaacatat aataaattta
     3181 ttgctattgt ttataaaaga ataaatgata tttttt
//

